DE60118409D1 - Herstellungsverfahren von immunglobulinen, die gegen menschlische thymozyten gerichtet sind - Google Patents

Herstellungsverfahren von immunglobulinen, die gegen menschlische thymozyten gerichtet sind

Info

Publication number
DE60118409D1
DE60118409D1 DE60118409T DE60118409T DE60118409D1 DE 60118409 D1 DE60118409 D1 DE 60118409D1 DE 60118409 T DE60118409 T DE 60118409T DE 60118409 T DE60118409 T DE 60118409T DE 60118409 D1 DE60118409 D1 DE 60118409D1
Authority
DE
Germany
Prior art keywords
manufacturing
directed against
against human
human thymocytes
immunoglobulins directed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60118409T
Other languages
English (en)
Other versions
DE60118409T2 (de
Inventor
Jerome Tiollier
Laurent Sorlin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Polyclonals SAS
Original Assignee
Imtix Sangstat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imtix Sangstat filed Critical Imtix Sangstat
Publication of DE60118409D1 publication Critical patent/DE60118409D1/de
Application granted granted Critical
Publication of DE60118409T2 publication Critical patent/DE60118409T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Transplantation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
DE60118409T 2000-09-28 2001-09-25 Herstellungsverfahren von immunglobulinen, die gegen menschliche thymozyten gerichtet sind Expired - Lifetime DE60118409T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0012384A FR2878852B1 (fr) 2000-09-28 2000-09-28 Procede de production d'immunoglobulines anti-thymocytes humains
FR0012384 2000-09-28
PCT/FR2001/002972 WO2002026830A1 (fr) 2000-09-28 2001-09-25 Procede de production d'immunoglobulines anti-thymocytes humains

Publications (2)

Publication Number Publication Date
DE60118409D1 true DE60118409D1 (de) 2006-05-18
DE60118409T2 DE60118409T2 (de) 2006-11-16

Family

ID=8854797

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60118409T Expired - Lifetime DE60118409T2 (de) 2000-09-28 2001-09-25 Herstellungsverfahren von immunglobulinen, die gegen menschliche thymozyten gerichtet sind

Country Status (9)

Country Link
US (2) US7528240B2 (de)
EP (1) EP1320552B8 (de)
JP (1) JP4777599B2 (de)
AT (1) ATE321787T1 (de)
AU (1) AU2001291993A1 (de)
CA (1) CA2423708A1 (de)
DE (1) DE60118409T2 (de)
FR (1) FR2878852B1 (de)
WO (1) WO2002026830A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL145279A0 (en) * 2001-09-04 2002-06-30 Yeda Res & Dev Antibodies against caspase-8, their preparation and use
WO2006064373A2 (en) * 2004-12-16 2006-06-22 Genzyme Polyclonals S.A.S. Methods of purifying immunologlobulins
FR2974369B1 (fr) 2011-04-20 2014-10-31 Genzyme Polyclonals S A S Amplification de cellules t regulatrices a l'aide d'immunoglobulines anti-thymocytes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364935A (en) * 1979-12-04 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to a human prothymocyte antigen and methods of preparing same
DE3105150A1 (de) * 1981-02-12 1982-08-19 Dr. Eduard Fresenius, Chemisch-pharmazeutische Industrie KG, 6380 Bad Homburg Herstellung von anti-t-lymphozyten-globulin.
US4464935A (en) * 1983-05-09 1984-08-14 General Electric Company Shaft vibration evaluation
US5304637A (en) * 1987-07-13 1994-04-19 Gist-Brocades N.V. Expression and purification of human interleukin-3 and muteins thereof
US5578480A (en) * 1993-04-23 1996-11-26 American Cyanamid Company Methods for the isolation and purification of the recombinantly expressed chondroitinase I and II enzymes from P. vulgaris
JP3445038B2 (ja) * 1995-09-26 2003-09-08 サントリー株式会社 精神的ストレス性障害関連抗原の測定法
AU3096099A (en) * 1998-03-18 1999-10-11 Sangstat Medical Corporation Immunomodulatory fragments of polyclonal antilymphocyte globulins (algs) and uses thereof

Also Published As

Publication number Publication date
AU2001291993A1 (en) 2002-04-08
US20040023340A1 (en) 2004-02-05
JP4777599B2 (ja) 2011-09-21
EP1320552B8 (de) 2006-06-07
US20090181043A1 (en) 2009-07-16
EP1320552B1 (de) 2006-03-29
FR2878852B1 (fr) 2007-02-23
US7528240B2 (en) 2009-05-05
DE60118409T2 (de) 2006-11-16
WO2002026830A1 (fr) 2002-04-04
ATE321787T1 (de) 2006-04-15
CA2423708A1 (fr) 2002-04-04
EP1320552A1 (de) 2003-06-25
JP2004509977A (ja) 2004-04-02
FR2878852A1 (fr) 2006-06-09

Similar Documents

Publication Publication Date Title
MXPA03004793A (es) Roedores transgenicos transcromosomales para elaborar anticuerpos humnanos.
NL1017508A1 (nl) Formatiebehandelingswerkwijze die vervormbare deeltjes gebruikt.
NL300163I1 (nl) Vermenselijkte anti-CD1 11a-antilichamen.
NL1001927A1 (nl) Telecommunicatiewerkwijze.
TR199600126A1 (tr) Naftil bilesikleri, ara ürünler, bilesimler ve yöntemler.
DE60217698D1 (de) Behandlung chronischer gelenkentzündung unter verwendung eines antikörpers gegen das cd3 antigenkomplex
DK1263790T3 (da) Monoklonale antistoffer for den humane LDL-receptor, deres produktionsmetode og anvendelse
DE69709655T2 (de) Verfahren zur herstellung von 17-estern von 9alpha,21-dihalopregan-11beta,17alpha-diol-20-onen
DE60118409D1 (de) Herstellungsverfahren von immunglobulinen, die gegen menschlische thymozyten gerichtet sind
ID22194A (id) Metode untuk menghasilkan vinil asetat
EP1621616A4 (de) Menschlicher anti-mensch-interleukin-18-antikörper, fragment davon und verfahren zu deren verwendung
ID20093A (id) Metode untuk memproduksi polibutilena tereptalat
NL1000487C2 (nl) Oogstmachine.
DE60121757D1 (de) Verfahren zur herstellng von membranen und die damit erhaltenen membranen
TR199600104A2 (tr) Hamur bandlarinin imal edilmesine mahsus tertibat.
TR199501276A2 (tr) Sübstitüe edilmis sikloalkilamino-ve-alkoksi-heterosaykillar, üretilmelerine mahsus usul ve zararlilarla mücadele maddesi olarak kullanilmalari.
ID30126A (id) METODE UNTUK MENGHASILKAN SIKLO-(Asp-DPhe-NMeVal-Arg-Gly)
NL1000309C1 (nl) Telefoontoestel.
NO986190D0 (no) FremgangsmÕte for syntetisering av stumme konsonanter
EP2270054A3 (de) Anti-Idiotyp-Antikörper des humanen monoklonalen Antikörpers SC-1 sowie ihre Herstellung und Verwendung
DE60107275D1 (de) Tetrahydrocarbazole, verfahren zur herstellung dieser verbindungen sowie deren verwendung
DE69606389D1 (de) Tricyclocarboxylate, verfahren zur herstellung sowie darauf basierendes parfum
MXPA03006932A (es) Derivado de indolina y procedimiento para la produccion del mismo.
TR199801514A3 (tr) N-Piruvil-L-Prolin üretimi için yöntem.
EA199800028A1 (ru) Винилсульфоксиды и способы их синтеза

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: GENZYME POLYCLONALS SAS, CHAMPAGNE AU MONT D*OR, F

8364 No opposition during term of opposition